Covered recipient · General Payments record
CAROLA E ROBINSON
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$4,528.53
- Reported across 235 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.82 | 13 |
| Education | $26.70 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MILLICENT US INC | $79.40 | 5 |
| Astellas Pharma US Inc | $78.57 | 3 |
| Exeltis, USA Inc. | $26.43 | 1 |
| Hologic Sales and Service, LLC | $23.67 | 1 |
| ABBVIE INC. | $21.61 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $20.92 | 1 |
| PFIZER INC. | $19.34 | 1 |
| Organon LLC | $18.56 | 1 |
| Amgen Inc. | $16.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.61 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103263435 | CMS |
| Amgen Inc. | $16.02 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111689900 | CMS |
| Astellas Pharma US Inc | $24.25 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139291188 | CMS |
| Astellas Pharma US Inc | $26.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139415429 | CMS |
| Astellas Pharma US Inc | $27.69 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139435732 | CMS |
| Exeltis, USA Inc. | $26.43 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149985389 | CMS |
| Hologic Sales and Service, LLC | $23.67 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084865747 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $20.92 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154670831 | CMS |
| MILLICENT US INC | $13.35 | 07/25/2024 | Education | Undisputed | 01/23/2026 | 1150904434 | CMS |
| MILLICENT US INC | $20.09 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150904436 | CMS |
| MILLICENT US INC | $13.35 | 09/19/2024 | Education | Undisputed | 01/23/2026 | 1150904438 | CMS |
| MILLICENT US INC | $14.45 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150904440 | CMS |
| MILLICENT US INC | $18.16 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150904442 | CMS |
| Organon Llc | $18.56 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193083 | CMS |
| PFIZER INC. | $19.34 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131592975 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.